MNPR vs TSLA · $431.4M cap vs P/E 179, rev $28.24B
Monopar Therapeutics Inc (MNPR) versus Tesla Inc (TSLA) — a side-by-side from cached financials, not a winner call.
Monopar Therapeutics Inc (MNPR) is a biotechnology company listed on US.
Tesla Inc (TSLA) is a auto manufacturers company listed on US. It is led by Elon Musk.
Latest reported MNPR revenue for 2026-06-30 was $0. Net income was -$9.2M. MNPR currently screens at market cap $431.4M.
Latest reported TSLA revenue for 2026-06-30 was $28.24B. Net income was $1.11B. Revenue was up 26.1% from 2026-03-31 to 2026-06-30. TSLA currently screens at market cap $976.12B and trailing P/E 179.1.
MNPR currently screens at market cap $431.4M. TSLA currently screens at market cap $976.12B and trailing P/E 179.1.
Not investment advice. Open the MNPR and TSLA stock pages for the full models.
Not investment advice.